#$%^&*AU2018241209A120181101.pdf#####ABSTRACT This invention provides peptides, immunogenic compositions and vaccines, and methods of treating, reducing the incident of, and inducing immune response to a WT1-expressing cancer, comprising heteroclitic peptides derived from the WT-1 protein.